The Hustlers of the U.S. Health Care System

Every time you buy a drug at a pharmacy — be it by prescription or over the counter — there’s a middleman that makes a huge profit…

And it doesn’t matter what pharmacy you go to, either. It could be Walgreens, Rite Aid or part of a larger, more integrated health care network… Regardless, the middleman, called a pharmacy benefit manager (or “PBM”), is there taking his cut.

While most PBMs are privately held firms (such as Benecard Services, Innoviant Inc. or WellDyne Inc.), some are publically traded… they could turn out to be the safest way to make money in America over the coming years…

If you haven’t heard of this industry, you may be surprised to find out how tied in it is with individuals and companies — big and small. They are the hustlers of the U.S. healthcare system.

According to BusinessWeek:

“America’s pharmacy benefit managers (PBMs) administer prescription drug benefits for more than 210 million Americans, whose health coverage is provided by Fortune 500 employers, health insurers, labor unions and Medicare Part D.”

Here’s how these companies make their money…

Whenever you go to the pharmacy, you take a special card in order to get your prescription filled. That card, depending on your company’s health benefit package, grants you access to your medication.

The pharmacist checks out your card, figures out which pills your package covers and — under pharmacy guidelines — determines which pill to offer you at what price.

What you’re not told is that the PBM, contracted by companies or health insurers to manage the pharmacy benefits of your health plan, makes all the decisions.

And their decisions are guided by one goal: They want to keep your company’s or health insurer’s spending on pharmaceuticals low.

The best way to do that — and the best way for them to make money themselves — is simple: They issue cheaper generic drugs to you.

Most people tend to be brainwashed by superficial brand loyalty, when they could be getting the exact same thing generically for a huge discount.

Take the example of a cholesterol-lowering drug. It’s basically the same case. You’ll be asked if you want to pay $30 and get a generic cholesterol-lowering pill or you could pay $200 to get something like Lipitor.

Again, generic drugs are tested, and for most people, they provide the same benefit. So unless your doctor insists on the specific brand, you’re going to choose generic.

PBMs love generics because they can aggregate the demand for various cholesterol-lowering drugs based on all the contracts they have with their clients. Then they buy generics in bulk at dirt-cheap prices, mark them up 20-50% and resell them to you.

This is actually a win-win scenario. And if you’re invested in a PBM, it’s a win-win-win scenario. Here’s why…

First, the PBM is saving your company money through lower pharmaceutical spending. Second, your copay is much cheaper than if you were forced to buy the branded pill. And third, the PBM makes a nice profit for itself and its shareholders by reselling the generic drug to customers.

Any PBM that’s looking to increase the number of generics that its customers use translates to higher profits.

Now, let’s review this in the context of tomorrow’s trends…

There are fewer generic drugs coming over the next two years. Last year, for example, according to The New York Times:

“More than 40 brand-name drugs — valued at $35 billion in annual sales — lost their patent protection, meaning that generic companies were permitted to make their own lower-priced versions of well-known drugs…”

But next year…

“the value of drugs scheduled to lose their patents and be sold as generics is expected to decline by more than half, to about $17 billion, according to an analysis by Credit Agricole Securities. ‘The patent cliff is over,’ said Kim Vukhac, an analyst for Credit Agricole. ‘That’s great for large pharma, but that also means the opportunities theoretically have dried up for generics.'”

That’s good news for large generics company Watson Pharmaceuticals, which just merged with and is renamed Actavis…launching it from the fifth to the third-largest generic drugmaker worldwide.

Any PBMs that can claim a large share in the shrinking generics supply could do very well.

Other PBM’s, like the company Actavis, could do very well by developing biosimilars, or generic biotech drugs. Biotech drugs are more expensive than pharmaceuticals. That means that generic biotech drugs have the potential to be more profitable than generic pharmaceuticals. The first of these new drugs will be showing up soon.

Teva Pharmaceuticals, which formed a partnership with Swiss company Lonza, is another example of a company on the road to develop biosimilars.

Two other big reasons these PBMs could become cash cows… If you’re an avid Tomorrow in Review reader, you know about them already: Obamacare and baby boomers.

Obamacare is going to bring another 38 million-some people into the health care system. Many will start using prescription drugs, and they’ll be put on generics through a PBM.

Plus, 76 million-some baby boomers are going to become senior citizens in the next 20 years. They’ll use more prescription drugs as they get older. Lots of generics are going to be used by baby boomers.

For more publically traded PBMs, you can check out the three largest: Caremark (NYSE: CVS), and Express Scripts (NASDAW: ESRX), and Catamaran Corp. (NASDAQ: CTRX).

Best,

Josh Grasmick
Article originally appeared here.

  • The Silent “Healthcare Exodus”

    The Silent “Healthcare Exodus”

    Chris Campbell

    by Chris Campbell
    On Jan 28, 2015

    1.25 million Americans will go abroad for health care services. But there’s another “silent exodus” happening in the health care industry that you should know about. Chris Campbell reports in from Bangkok. Read on…

  • "Bangkok Has Him Now, and She'll Never Let Him Go"

    “Bangkok Has Him Now, and She’ll Never Let Him Go”

    Chris Campbell

    by Chris Campbell
    On Jan 21, 2015

    Ever considered medical tourism? If not, maybe you should. Chris Campbell tells you why. Read on…

    An article in ,

  • Motorbikes, Cockfights, and Laser Beams

    Motorbikes, Cockfights, and Laser Beams

    Chris Campbell

    by Chris Campbell
    On Jan 20, 2015

    The adventure begins. Chris Campbell reports in from Bangkok. And you’ll never believe what he’s already gotten himself into. Read on…

  • The Patient Will See You Now

    The Patient Will See You Now

    Chris Campbell

    by Chris Campbell
    On Jan 16, 2015

    Worried about the direction our health care system is headed? Don't be! Chris Campbell investigates the phoenix to rise out of the ashes of the ruins. Read on...

  • Sit Down While We Predict Your Future

    Sit Down While We Predict Your Future

    Chris Campbell

    by Chris Campbell
    On Jan 8, 2015

    Ready to have your fortune told? Chris Campbell invites the Laissez Faire crew to give their most shocking predictions for 2015. Each one could affect your health, wealth, and happiness. Read on...

  • SHI_MultiBillionDollar

    The Multibillion-Dollar Name Game

    Ryan Cole

    by Ryan Cole
    On Jan 9, 2015

    We’ve come to realize that the best opportunity in real estate isn’t in the physical world. After all, everyone knows — they aren’t making any more beaches. Physical real estate is a game of shuffle. You have to buy a plot or a house — already at a high price. Luckily, I’ve discovered an entirely different kind of real estate. Not land — not anymore. New millionaires are being minted every day in a very 21st-century kind of real estate. One without the limitations of the physical world.

     

  • Blowing Smoke Up Your Butt

    Blowing Smoke Up Your Butt

    Chris Campbell

    by Chris Campbell
    On Jan 7, 2015

    Do you know where the expression “blowing smoke” comes from? From an old -- and very strange -- medical device. You won’t believe what else Chris Campbell has unearthed from the olden days of strange medicine. Read on…

  • Of Brands, Beef, and Bungled Biomass

    Of Brands, Beef, and Bungled Biomass

    Chris Campbell

    by Chris Campbell
    On Dec 23, 2014

    Milk. Meat. Butter. How carefully are you choosing these three staples? According to our own underground health researcher Nate Rifkin, it’s probably not carefully enough. Inside, Nate will show you precisely what to look for when you go to the supermarket… and how to avoid the toxic swill. Read on…

  • Big Pharma’s Slimy Tactics to Convince You You’re Sick

    Big Pharma’s Slimy Tactics to Convince You You’re Sick

    Chris Campbell

    by Chris Campbell
    On Dec 16, 2014

    Big Pharma is on a quiet rampage of disease-mongering. Every sniffle is an acronym. Every sneeze, the onset of some horrible disease. Chris Campbell, suffering through actual sickness, explores Big Pharma’s slimy tactics. And he digs into what you can do to protect yourself. Read on…

  • Why Governments Love Destruction (and Always Fail to Act)

    Why Governments Love Destruction (and Always Fail to Act)

    Chris Campbell

    by Chris Campbell
    On Nov 3, 2014

    You should be celebrating the coming Syrian war and Ebola. After all, they’re set to stimulate the economy, no? Chris Campbell explores this insane paradigm and uncovers what would happen if the government got out of the way. Read on…

  • OilMarkets

    What in the World Is Going on in the Oil Markets?

    Byron King

    by Byron King
    On Jan 6, 2015

    By the time you receive this month’s issue, your New Year’s hangover should be a distant memory. Your empty champagne bottles are on the curb waiting for the holiday-weary recycling guy, your house guests are long gone, and you’re just days into your New Year’s resolutions. Ahh yes. It’s the time of year when hope springs eternal. A time when anything and everything is possible. It is a new year, after all, and we have 365 days (give or take) to make 2015 your best year yet.

     

  • Why Sound Investors Choose Gold and... Ebola?

    Why Sound Investors Choose Gold and… Ebola?

    Chris Campbell

    by Chris Campbell
    On Oct 29, 2014

    Savvy investors: Two experts weigh in on why having your own personal gold standard… and betting that Ebola will get worse… could be your best investment decisions of 2014. Read on…

  • The End of Cancer in Your Lifetime? One Picture Has the Answer

    The End of Cancer in Your Lifetime? One Picture Has the Answer

    Chris Campbell

    by Chris Campbell
    On Oct 28, 2014

    Will you see the end of cancer in your lifetime? One revealing picture says it all. Learn how scientists are creating super immunities… and what it could mean for your portfolio. Read on…

    An article in

  • These Three Ebola Bombshells Change Everything

    These Three Ebola Bombshells Change Everything

    Chris Campbell

    by Chris Campbell
    On Oct 16, 2014

    Today, Chris Campbell reveals three pieces of news -- that just surfaced in the past 24 hours -- that could change everything. One, the CDC has failed tremendously already and has put the whole of United States in danger. Second, nurses in the United States are not ready for Ebola. Third, scientific evidence exists that Ebola is airborne through aerosols. Read on…

    An article in , ,

  • What You Need to Know: Inside the World’s Largest Ebola Symposium

    What You Need to Know: Inside the World’s Largest Ebola Symposium

    Chris Campbell

    by Chris Campbell
    On Oct 15, 2014

    Chris Campbell is in a room full of more doctors than in all of Liberia. And they’re all there for one purpose: to talk about Ebola. He “snuck” inside the world’s largest Ebola Symposium at Johns Hopkins University. What the panel of speakers are saying boils down to one thing: the government doesn’t know as much as they say… and yes, it’s OK to be worried. Don’t miss this explosive inside report. Read on…

    An article in , ,

  • shutterstock_83366287

    The Story of a Reluctant Winemaker

    Joe Maga

    by Joe Maga
    On Dec 15, 2014

    Sometimes life deals you lemons. It’s up to you to make lemonade. This month’s Insider Cellar recommended winemaker had no intention of making wine when his family settled just north of Santa Barbara. When our reluctant winemaker’s father walked his land in the early 1980s, he was probably disappointed when he discovered the soil did not have the nutrients to support his strawberry crop

     

  • Own a Gun? Ebola is Your Fault

    Own a Gun? Ebola is Your Fault

    Chris Campbell

    by Chris Campbell
    On Oct 14, 2014

    As the Ebola crisis continues, says MSNBC, guns are to blame for the fear of the masses. In today’s Laissez Faire Today, Chris Campbell looks into the mainstream’s hype… Connecticut’s declaration of public emergency… why Americans are buying Ebola plush dolls... how Chris will sneak into the biggest Ebola conference in the world… and much more. Read on…

    An article in , ,

  • Breaking: On the Ground in Liberia [VIDEO]

    Breaking: On the Ground in Liberia [VIDEO]

    Chris Campbell

    by Chris Campbell
    On Oct 10, 2014

    Cut through all the clutter and see what’s really happening in Liberia. In today’s issue of Laissez Faire Today, Chris Campbell shows you why the CDC is downplaying the situation, and why you still shouldn’t freak out (yet). Read on…

    An article in , ,

  • One Potential Ebola Treatment You’re Not Being Told About

    One Potential Ebola Treatment You’re Not Being Told About

    Chris Campbell

    by Chris Campbell
    On Oct 9, 2014

    The government is on a mad race to create a vaccine for Ebola. What they aren’t telling you is that, in 2003, they may have found a way to beat it naturally. According to one unclassified government document, this little-known plant beat Ebola 90% of the time. Why isn’t the government developing it? Read on…

  • Survive Ebola: Become a “White Blood Cell” For Mankind

    Survive Ebola: Become a “White Blood Cell” For Mankind

    Chris Campbell

    by Chris Campbell
    On Oct 8, 2014

    Ebola isn’t just spreading. According to one doctor, it could be getting stronger by the day. In today’s Laissez Faire Today, you’ll learn the quick-and-dirty guide to surviving if Ebola comes to your hometown. And eight essential natural medicines to fight Ebola. Read on…

  • SHI0115

    The Only Path to the American Dream

    Ryan Cole

    by Ryan Cole
    On Dec 10, 2014

    This month, I’m going to tell you a hard truth. It’s one that Wall Street brokers and financial analysts try to hide. It’s one that most newsletter writers choose to ignore. In fact—when it comes to the financial world—this is a “secret” that everyone knows… but no one will mention.

     

  • ISIS, Ebola Uncut: Why the Mainstream is Late Wrong and Corrupt

    ISIS, Ebola Uncut: Why the Mainstream is Late Wrong and Corrupt

    Chris Campbell

    by Chris Campbell
    On Oct 7, 2014

    The mainstream media has been complacent in reporting the truth about Ebola. They’re not telling the truth about how dangerous the Ebola situation really is. Because of this, millions of lives are at risk. Inside today’s Laissez Faire Today, learn what the mainstream should be telling you about how to protect yourself in the case of an outbreak in the United States. Read on…

  • SourMilk

    Don’t Drink the Tap Water… or the Milk (It’s Not What You Think!)

    Chris Campbell

    by Chris Campbell
    On Oct 1, 2014

    Instead of letting you choose, the government has found it fit to force one potentially dangerous medication on you and your family. Where is it? In your drinking water. Even more outrageous: While Uncle Sam forces medication down your throat, he also says you have no right to choose your own milk. Chris Campbell has all the details. Read on…

  • Escape Obamacare in One Bold Move

    Escape Obamacare in One Bold Move

    Chris Campbell

    by Chris Campbell
    On Sep 19, 2014

    Think it’s impossible to escape Obamacare? Think again. Laissez Faire Today reader David F. shares how he did it and how you can do it too. Don’t see another doctor, take another pill, or shop around for better medical insurance until you read his story. Read on…

  • The Other Epidemic (and How to Stop it)

    The Other Epidemic (and How to Stop it)

    Chris Campbell

    by Chris Campbell
    On Sep 16, 2014

    “While I heartily subscribe to your premise of pursuing one’s dream,” one reader, Donald J., wrote, “there are alternate perspectives worth considering.”[We’re listening… go on.]“Some wiseguy once said that life is what happens to you while you’re waiting for something better to come along. Milton put it a little more poetically in one of his […]

  • TimeBomb

    Three Time Bombs in Your 401(k)

    Dave Gonigam

    by Dave Gonigam
    On Dec 4, 2014

    They lurk somewhere in everyone’s 401(k) program. Tick, tick… And it might be years before you discover them. Tick, tick… By the time you do… Kaboom! It’s too late. They’ve already blown up your retirement.

     

  • The Only Way to Get Rich: A Zen Proverb

    The Only Way to Get Rich: A Zen Proverb

    Chris Campbell

    by Chris Campbell
    On Sep 10, 2014

    Want to get rich? Don’t listen to financial “gurus,” says Chris Campbell. In today’s Laissez Faire Today, Chris shares a Zen proverb and shows how understanding it is the only real way to get rich (and live a rich life). Read on…

  • HappyFamily

    One Free Website to Keep Your Family Safe

    Chris Campbell

    by Chris Campbell
    On Sep 9, 2014

    Ben Franklin once said, “An ounce of prevention is worth a pound of cure.” In today’s Laissez Faire Today, you’ll learn about one FREE website that has the potential to not only keep your family safe – but also open your eyes to what’s happening in your own neighborhood. Chris Campbell has all the details. Read on…

  • Youre_Incredible

    Use “Power Gaps” to Build Your Own Empire

    Chris Campbell

    by Chris Campbell
    On Sep 8, 2014

    All over the world, power is dying. The dictators and tyrants of the world are no longer able to wield it like they once used to. And they’re losing it to the “little guy.” Chris Campbell shows you how to be the king of your castle by taking advantage of this fact. Today, you’ll learn how to grab “power gaps” in the market and channel them into your product idea or project. Read on…

  • Free Markets and Malaysian Fireflies

    Free Markets and Malaysian Fireflies

    Chris Campbell

    by Chris Campbell
    On Sep 3, 2014

    The fireflies along the tidal rivers of Malaysia show "feats of synchrony that occur spontaneously, almost as if nature has an eerie yearning for order." Chris Campbell tells you where else this might occur in the world. Also, new technology may revolutionize the agriculture industry and what we think of as a farm.

  • SHI_December2014

    This Sector Is Ready to Explode 1,000% Higher

    Ryan Cole

    by Ryan Cole
    On Dec 1, 2014

    One industry is expected to grow from an estimated $77 billion sector by the end of 2014… to around $700 billion in 2024. And that, frankly, is a conservative estimate, as you’ll see below. This isn’t because of some resource boom or new discovery. This isn’t because of funny business or a trader play. This is real spending, done by real companies to combat a very real threat. It’s already an established industry but poised for exponential growth. Because the problem it combats is growing exponentially.

     

  • Smoking Pot in the Governor’s Mansion

    Smoking Pot in the Governor’s Mansion

    Chris Campbell

    by Chris Campbell
    On Sep 2, 2014

    Jeff Davis is running for Governor in Hawaii and has an interesting campaign strategy. Also, what motivates hackers is revealed and the findings might surprise you. Finally, Ferguson is discussed in a new light. Chris Campbell has more...

  • Central Planning by Central Bankers

    Central Planning by Central Bankers

    Gary North

    by Gary North
    On Aug 15, 2014

    In a 2009 article, the Huffington Post went into considerable detail about the number of people with PhD degrees in economics employed by the Board of Governors of the Federal Reserve System. This is the government’s branch of the Federal Reserve. It is not one of the 12 regional Federal Reserve banks, all of which […]